• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性膀胱过度活动症药物处方率的季节性变化:一项全国性基于人群的研究。

Seasonal variations in overactive bladder drug prescription rates in women: a nationwide population-based study.

机构信息

Department of Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, 211 Eonju-ro, Gangnam-gu, Seoul, 06273, Korea.

Data Science Team, Hanmi Pharmaceutical. Co. Ltd., Seoul, Korea.

出版信息

World J Urol. 2021 Mar;39(3):877-882. doi: 10.1007/s00345-020-03257-1. Epub 2020 May 20.

DOI:10.1007/s00345-020-03257-1
PMID:32436073
Abstract

PURPOSE

Colder seasons can aggravate lower urinary tract symptoms, especially an overactive bladder (OAB). This aspect has been extensively studied in men and rarely in women. We investigated whether colder seasons influence OAB-drug prescription rates (OAB-DPRs) in women.

METHODS

Women aged > 18 years were selected from the Korean Health Insurance Review and Assessment Service-National Patient Sample data between 2012 and 2016. OAB-DPR was calculated according to age and seasonal groups. The prescription rates in summer (June, July, and August) and winter (January, February, and December) months were compared. Sub-analysis was performed according to age group.

RESULTS

In total, 3,061,343 adult women were included. The overall OAB-DPR was 3.75% (114,940/3,061,343). Overall OAB-DPRs in summer and winter were 1.41% (43,090/3,061,343) and 1.54% (47,038/3,061,343), respectively (p < 0.001). Seasonal variations in OAB-DPRs differed by age group (p < 0.001): OAB-DPRs were significantly lower in winter than in summer months in women aged < 50 years (odds ratio 0.942; 95% confidence interval 0.918-0.967; p < 0.001), but significantly higher in winter than in summer months in women aged ≥ 50 years (odds ratio 1.153; 95% confidence interval 1.135-1.171; p < 0.001).

CONCLUSION

In this study, a correlation was noted between OAB-DPR and seasons. OAB-DPRs were higher in the summer in women aged < 50 years and higher in the winter in women aged ≥ 50 years. Our findings suggest that female hormonal status may be involved in the contradictory effect of seasons on OAB symptoms.

摘要

目的

寒冷季节会加重下尿路症状,尤其是膀胱过度活动症(OAB)。这方面在男性中已得到广泛研究,但在女性中很少研究。我们调查了寒冷季节是否会影响女性的 OAB 药物处方率(OAB-DPR)。

方法

我们从 2012 年至 2016 年的韩国健康保险审查和评估服务-国家患者样本数据中选择了年龄大于 18 岁的女性。根据年龄和季节组计算 OAB-DPR。比较了夏季(6、7、8 月)和冬季(1、2、12 月)的处方率。根据年龄组进行了亚组分析。

结果

共有 3061343 名成年女性入组。总体 OAB-DPR 为 3.75%(114940/3061343)。夏季和冬季的总体 OAB-DPR 分别为 1.41%(43090/3061343)和 1.54%(47038/3061343)(p<0.001)。OAB-DPR 随年龄组的季节性变化不同(p<0.001):<50 岁的女性冬季 OAB-DPR 明显低于夏季(比值比 0.942;95%置信区间 0.918-0.967;p<0.001),但≥50 岁的女性冬季 OAB-DPR 明显高于夏季(比值比 1.153;95%置信区间 1.135-1.171;p<0.001)。

结论

在这项研究中,OAB-DPR 与季节之间存在相关性。<50 岁女性夏季 OAB-DPR 较高,≥50 岁女性冬季 OAB-DPR 较高。我们的研究结果表明,女性激素状态可能与季节对 OAB 症状的相反影响有关。

相似文献

1
Seasonal variations in overactive bladder drug prescription rates in women: a nationwide population-based study.女性膀胱过度活动症药物处方率的季节性变化:一项全国性基于人群的研究。
World J Urol. 2021 Mar;39(3):877-882. doi: 10.1007/s00345-020-03257-1. Epub 2020 May 20.
2
Seasonal Variation of Drug Prescription Rate for Overactive Bladder in Men Based on National Health Insurance Claims Data, 2012-2016.基于2012 - 2016年国家医疗保险理赔数据的男性膀胱过度活动症药物处方率的季节性变化
Int Neurourol J. 2020 Sep;24(3):278-285. doi: 10.5213/inj.2040030.015. Epub 2020 Sep 30.
3
Prevalence of overactive bladder in China, Taiwan and South Korea: Results from a cross-sectional, population-based study.中国、台湾地区和韩国膀胱过度活动症的患病率:一项基于人群的横断面研究结果
Low Urin Tract Symptoms. 2019 Jan;11(1):48-55. doi: 10.1111/luts.12193. Epub 2017 Oct 2.
4
Analysis of the prevalence of and factors associated with overactive bladder in adult Korean women.成年韩国女性膀胱过度活动症的患病率及相关因素分析。
PLoS One. 2017 Sep 28;12(9):e0185592. doi: 10.1371/journal.pone.0185592. eCollection 2017.
5
Antimuscarinic Medication Use in Elderly Patients with Overactive Bladder.抗毒蕈碱药物在老年膀胱过度活动症患者中的应用
Drugs Aging. 2016 Oct;33(10):755-763. doi: 10.1007/s40266-016-0399-5.
6
Primary Nonadherence to Overactive Bladder Medications in an Integrated Managed Care Health Care System.在综合管理式医疗保健系统中,膀胱过度活动症药物的原发性不依从。
J Manag Care Spec Pharm. 2017 Apr;23(4):484-493. doi: 10.18553/jmcp.2017.23.4.484.
7
Patterns of medical management of overactive bladder (OAB) and benign prostatic hyperplasia (BPH) in the United States.美国过度膀胱活动症(OAB)和良性前列腺增生(BPH)的医疗管理模式。
Neurourol Urodyn. 2018 Jan;37(1):213-222. doi: 10.1002/nau.23276. Epub 2017 Apr 28.
8
Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence.托特罗定缓释片对患有膀胱过度活动症和急迫性尿失禁的性活跃女性患者报告结局的影响。
Curr Med Res Opin. 2009 Sep;25(9):2159-65. doi: 10.1185/03007990903103279.
9
Overactive bladder in an integrated delivery system: a longitudinal cohort study.综合医疗服务体系中的膀胱过度活动症:一项纵向队列研究。
BMC Health Serv Res. 2020 May 20;20(1):447. doi: 10.1186/s12913-020-05315-1.
10
Mirabegron Add-on Therapy to Tamsulosin for the Treatment of Overactive Bladder in Men with Lower Urinary Tract Symptoms: A Randomized, Placebo-controlled Study (MATCH).米拉贝隆附加疗法联合坦索罗辛治疗男性下尿路症状伴膀胱过度活动症:一项随机、安慰剂对照研究(MATCH)。
Eur Urol Focus. 2020 Jul 15;6(4):729-737. doi: 10.1016/j.euf.2019.10.019. Epub 2019 Nov 11.

引用本文的文献

1
Efficacy of high-dose vitamin D supplementation vs. solifenacin or standard urotherapy for overactive bladder dry in children: a secondary analysis of a randomized clinical trial.高剂量维生素 D 补充剂与索利那新或标准尿路治疗对儿童膀胱过度活动症(无湿)的疗效比较:一项随机临床试验的二次分析。
World J Urol. 2024 Oct 22;42(1):586. doi: 10.1007/s00345-024-05296-4.

本文引用的文献

1
Human physiological responses to cold exposure.人体对寒冷暴露的生理反应。
Aviat Space Environ Med. 2004 May;75(5):444-57.